Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer.
about
Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigationFive recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.Clinical interpretation and implications of whole-genome sequencing.Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional ImplicationsTracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?Inherited and acquired alterations in development of breast cancer.HER2-positive male breast cancer: an update.High prevalence of a BRCA1 gene founder mutation, 5083del19, in unselected breast–ovarian cancer patients from Southern Italy: genotype–phenotype correlations.Reconstructing the genealogy of a BRCA1 founder mutation by phylogenetic analysis.High Resolution Melting Analysis is Very Useful to Identify Breast Cancer Type 1 Susceptibility Protein (BRCA1) c.4964_4982del19 (rs80359876) Founder Calabrian Pathogenic Variant on Peripheral Blood and Buccal Swab DNA.
P2860
Q31138109-7FA11CAC-0D05-4F50-A95F-419F58D08DF6Q33368443-1347942F-7E18-4608-AEFA-CCCA5D6EB8EBQ33989890-834151EB-5338-4605-A226-12D9F1CD73C6Q35659498-4A68743F-9274-4FF8-8544-270779DD0A87Q35916613-CB674E68-1C23-4508-9D47-2BE2D47C1896Q36117690-7C1C4215-B101-4696-9443-CC4F43EB9064Q36689744-10012FF3-176E-4A54-B93E-3D2436FEFD77Q36925229-A5CC38C2-4A2C-4D30-AD4A-9CF5ED413FE7Q37355586-6EC065E3-FA75-465D-BF22-D88F6D56B46FQ46119470-B6F63ECF-7AA9-4027-BBDB-AD72684CC396Q47284128-445E5ED6-38A1-4D98-8EEC-F7AF18D70532Q48844338-3C2BD8A5-95DF-489C-8244-BFE67AE003AD
P2860
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Evidence of a founder mutation ...... ly with breast/ovarian cancer.
@ast
Evidence of a founder mutation ...... ly with breast/ovarian cancer.
@en
Evidence of a founder mutation ...... ly with breast/ovarian cancer.
@nl
type
label
Evidence of a founder mutation ...... ly with breast/ovarian cancer.
@ast
Evidence of a founder mutation ...... ly with breast/ovarian cancer.
@en
Evidence of a founder mutation ...... ly with breast/ovarian cancer.
@nl
prefLabel
Evidence of a founder mutation ...... ly with breast/ovarian cancer.
@ast
Evidence of a founder mutation ...... ly with breast/ovarian cancer.
@en
Evidence of a founder mutation ...... ly with breast/ovarian cancer.
@nl
P2093
P50
P356
P1433
P1476
Evidence of a founder mutation ...... aly with breast/ovarian cancer
@en
P2093
Barbieri V
Conforti S
Faniello C
Ficorella C
Grandinetti C
Quaresima B
P304
P356
10.1002/HUMU.1167
P577
2001-08-01T00:00:00Z